This grant supports planning of cancer prevention and control clinical trials to enhance trial design, feasibility, and reduce costs for effective cancer interventions.
Facilitates well-planned cancer prevention and control clinical trials by addressing information gaps to improve trial design and feasibility, saving time and money for NCI.
This grant supports investigator-initiated clinical trials to reduce cancer burden through early detection, prevention, and survivorship improvements.
Support for innovative research to improve cancer control through behavior modification, screening, and understanding etiologic factors, with the aim of advancing population-based cancer studies.
Supporting essential pilot studies for NHLBI clinical trials, aiming to inform Phase II-IV trial planning for heart, lung, blood, and sleep disorders.
Research grant to understand and treat long-term side effects of cancer therapy through mechanistic and clinical studies supporting therapeutic interventions.